diltiazem hydrochloride NDC 70771-1031

Product information

Brand name (proprietary)

diltiazem hydrochloride

Generic name (nonproprietary)

diltiazem hydrochloride

Active ingredients

Diltiazem hydrochloride — 180 mg/1

Dosage form

Capsule, Extended release

Route

Oral

Labeler

Zydus Lifesciences Limited

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 206534

Marketing start

Sep 28, 2017

Listing expires

Dec 31, 2026

Other FDA classes

Calcium Channel Antagonists (Mechanism)Cytochrome P450 3A4 Inhibitors (Mechanism)

Identifiers

Product ID 70771-1031_99889af0-9650-495d-9834-3cb0e77cda5eSPL ID 99889af0-9650-495d-9834-3cb0e77cda5eSPL set ID fe790439-85d4-4cd8-a385-149ea3442a38RxCUI 830795, 830801, 830837, 830845, 830861UNII OLH94387TE

Pharmacologic class

Calcium Channel Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470771103101 followed by a unit qualifier and the quantity Copy

Package 70771-1031-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Label details couldn’t be retrieved right now. Open the label on DailyMed.

Other NDCs under ANDA 206534

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.